等待开盘 10-31 09:30:00 美东时间
0.000
0.00%
 华盛通
华盛通Alnylam stock fell after a strong Q3 with $2.90 EPS and $1.25 billion revenue, a subpoena disclosure, and raised 2025 sales guidance to $3.6 billion–$3.8 billion.
今天 02:39
Alnylam shares are trading lower after the company disclosed it received a subp...
10-30 20:17
Alnylam Pharmaceuticals (NASDAQ:ALNY) is gearing up to announce its quarterly e...
10-29 22:04